Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3851786

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=S(=O)(CCO)c1cccc(N2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)c1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.49
CYP3A4 P08684 11/20 0.39
HPGD P15428 1/20 0.39
CYP1A2 P05177 9/20 0.39
CLK4 Q9HAZ1 9/20 0.39
MAPK1 P28482 6/20 0.39
LMNA P02545 5/20 0.39
HIF1A Q16665 5/20 0.39
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
USP2 O75604 6/20 0.38
CYP2C19 P33261 3/20 0.38
CYP2D6 P10635 3/20 0.38
ENPP1 P22413 1/20 0.37
HSD17B10 Q99714 2/20 0.37
TSHR P16473 2/20 0.37
KIT P10721 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13874748 0.94 AKT1 (0.50) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3850108 0.89 AKT1 (0.51) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3847446 0.89 AKT1 (0.49) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3851634 0.88 AKT1 (0.48) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3848184 0.87 AKT1 (0.48) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3847772 0.87 AKT1 (0.48) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3847451 0.87 AKT1 (0.49) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3849063 0.87 AKT1 (0.47) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL4712859 0.85 AKT1 (0.46) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3854776 0.85 AKT1 (0.48) AKT1CYP3A4HPGDCYP1A2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed